United States
2-bromobenzo[9,10]phenanthrene CAS NO.19111-87-6
- Min.Order: 0 Metric Ton
- Payment Terms:
- Product Details
Keywords
- phenanthrene
- 2-bromobenzo[9,10]phenanthrene
- OLED material
Quick Details
- ProName: 2-bromobenzo[9,10]phenanthrene
- CasNo: 19111-87-6
- Application: industrial/research use
- ProductionCapacity: Metric Ton/Day
- Purity: 99.89
- LimitNum: 0 Metric Ton
Superiority
How May We Serve You
We can Supply HPLC\HMMR\MS report for you ,pls feel free to contact us!
Capability on chemical synthesis
● Shanghai High-Tech Enterprises
● Strong R&D Team from USA, Japan, Korea
● 65000M2+ Factory, 300+ reactors, daily output at 100+ tons
● Reactor Size: 50L-20000L; Total volume:640000 liters
● Temperature range: -120°C ~ +300°C ; Pressure: vacuum up to 30 MP
● Organic Synthesis: High pressure reactors, Parr hydrogenator and Microwave reactor
Quality Control and Services
● Timely delivery,Competitive cost
● Leading OLED Materials Manufacturer
● Certified by ISO9001 & ISO14001
● Analytical laboratories:HPLC, LC-MS, GC, GC-MS, NMR ...
● Complete lot records and archived samples
● SMP Standard Management Procedure
● Strictly IP Protection,confidential services and quotations
● Strictly Quality incident management:deviation, OOS, customer complaint,product recall...
Details
Oral & Injectable Anabolic Steroid Hormones Anastrozole CAS 120511-73-1 Male Supplement With Anti-estrogen Arimidex
Quick Details:
- Anastrozole
- Alias :Arimidex ,Tetramethyl-5-(1H-1,2,4-triazol-1ylmethyl)1,3-benzenediacetionitrile
- CAS NO. : 120511-73-1
- Assay : 98%~102%
- Appearance : White crystalline powder
- Active life cycle : 6 hours
- MF : C17H19N5
- MW : 293.37
- Molecular Structure :
- Grade : Pharmaceutical Grade
- Storage: Shading, confined preservation
- Manufacturer : Hezhong
- Usage : Anastrozole is a potent non-steroidal aromatase inhibitors , which lead the decrease of plasma level of estrogen, inhibited the growth of breast cancer. For the treatment of advanced breast cancer in postmenopausal women patients.
Description :
Anastrozole is a drug indicated in the treatment of breast cancer in post-menopausal women. It is used both in adjuvant therapy (i.e. following surgery) and in metastatic breast cancer.
Many breast cancers also contain aromatase; the importance of tumor-generated estrogens is uncertain. Treatment of breast cancer has included efforts to decrease estrogen levels by ovariectomy premenopausally and by use of anti-estrogens and progestational agents both pre- and post-menopausally, and these interventions lead to decreased tumor mass or delayed progression of tumor growth in some women. Anastrozole is a potent and selective non-steroidal aromatase inhibitor. It significantly lowers serum estradiol concentrations and has no detectable effect on formation of adrenal corticosteroids or aldosterone.
Application:
Three azole aromatase inhibitors are potent selective, it can inhibit the cytochrome P-450 dependent aromatase thereby blocking the biosynthesis of estrogen, but estrogen is the main factor that stimulates the growth of breast cancer cells.
The treatment of breast cancer, especially for those with adjuvant hormone therapy after menopause after recurrence of women with advanced breast cancer.
Effects :
Anastrozole is more effective than previous drugs such as tamoxifen and crucially, it has fewer side effects . Anastrozole has been tested for reducing estrogens, including estradiol, in men.
Some athletes and body builders use anastrozole as part of their steroid cycle to reduce and prevent symptoms of excess estrogen--gynecomastia, emotional lability and water retention.
Bone weakness has been associated with anastrozole.